Modification to Verte-Stack Spinal System
by Medtronic Sofamor Danek, Inc. 9 variants
510(k) K023570
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK023570 | Date19 Nov 2002 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MQP
- FDA applicant
- Medtronic Sofamor Danek
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3060
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
This device is a modification to the Verte-Stack Spinal System, a spinal fixation system used in orthopedic procedures. It is designed to be used with various anterior fixation systems including the ZPLATE II, DYNALOK™ CLASSIC, VANTAGE™, TSRH®, CD HORIZON®, and GDLH® Spinal Systems, or their successors.
The device was cleared via the FDA 510(k) pathway under K023570, with a decision date of November 19, 2002, and is classified as substantially equivalent. It is manufactured by Medtronic Sofamor Danek, Inc. and is intended for use in spinal fixation procedures as part of a broader spinal system.
Other devices from Medtronic Sofamor Danek, Inc.
Questions
AI-generated answers, 26 Sep 2026
What is the Modification to Verte-Stack Spinal System used for?
This device is a modification to the Verte-Stack Spinal System and is intended for use in spinal fixation procedures as part of a broader spinal system. It is designed to be used with various anterior fixation systems including the ZPLATE II, DYNALOK™ CLASSIC, VANTAGE™, TSRH®, CD HORIZON®, and GDLH® Spinal Systems, or their successors, to provide stability during orthopedic spinal surgeries.
How is the Modification to Verte-Stack Spinal System supplied or packaged?
The device data does not specify how the Modification to Verte-Stack Spinal System is supplied, packaged, or whether it is sterile or single-use. Therefore, details about its physical form, packaging, sterility, or reusability cannot be determined from the provided information and should be obtained from the manufacturer's labeling or instructions for use.
What regulatory pathway was used for the Modification to Verte-Stack Spinal System?
The device was cleared via the FDA 510(k) pathway under submission number K023570, with a decision date of November 19, 2002. It was classified as substantially equivalent to a predicate device, meaning it demonstrated similar safety and effectiveness to a legally marketed device through the 510(k) submission process.